In this week’s Patent & Design News – “Innovate, Patent, Produce and Prosper,” says PM Narendra Modi; 12th edition of GIPC to be held in New Delhi, this week; IPO issues notification containing list of withdrawn patent applications; Taiho Pharmaceutical files patent infringement lawsuit against Natco Pharma; Eli Lilly wins lawsuit instituted against Apotex Inc. and other news updates.
India Patent News
12th edition of GIPC to be held in New Delhi, this week
The 12th edition of the Global Intellectual Property Convention (GIPC), Asia’s leading IP Convention on Innovation and IP, has been scheduled to be held between 8th and 10th January 2020. The Convention is being jointly organized by the Institute of International Trade Center (Center for WTO Studies) and ITAG Business Solutions Ltd, in New Delhi. Delegates from over 50 countries are expected to grace the occasion. Hon’ble Union Minister for Finance and Corporate Affairs, Govt. of India, Smt. Nirmala Sitharaman will address the gathering as the Chief Guest. Further, Plenary Sessions will be conducted on various dynamic topics like:
- Patent-Law-Based Concepts for Handling AI-created Inventions
- Patent Prosecution Highway – Collaboration is the key
- Patent Law and CRISPR-Cas9
- Interplay Between Designs, Copyright, and Trade Dress
- Open source and its impact on Patent Portfolio
- Competition Law and IPR: Mergers & Acquisitions
- Session on IP Data Mining and many more.
You may click here to access the official GIPC website.
“Innovate, Patent, Produce and Prosper,” says PM Narendra Modi
While delivering the inaugural address at the 107th establishment of the Indian Science Congress (ISC) at the University of Agricultural Sciences in Bangalore, Prime Minister, Shri Narendra Modi encouraged young scientists in the country to focus on innovation. The Prime Minister said that both Science and Technology play an essential role in contributing to the growth of India giving rise to the need of revolutionizing the ecosystem of ISC and innovation. The Prime Minister also coined a new motto for young scientists, being –“Innovate, Patent, Produce and Prosper.” According to the Prime Minister, these four essential steps carry the power to lead India towards the track of faster development and a “New India.” Shri Narendra Modi also highlighted the fact that India has made significant improvement in the Global Innovation Index ranking by securing the 52nd position in 2019 and added that India now stands at the 3rd position in the number of peer-reviewed Science and Engineering Publications, globally. By referring to the theme of the 107th ISC establishment, i.e., Science and Technology: Rural Development, the Prime Minister encouraged bright minds to innovate in the field of Rural Development.
You may click here to access the official press release.
IPO issues notification containing list of withdrawn patent applications
The Indian Patent Office has published a notification consisting of all patent applications that have been withdrawn through Form 29 between the period of October and December, 2019. According to the notification published on 3rd January 2020, over 950 applications have been with withdrawn in the aforementioned period. You may click here to access the same.
Patent Disputes / Infringements / Settlement and Licensing
Taiho Pharmaceutical files patent infringement lawsuit against Natco Pharma
Japanese pharmaceutical giant, Taiho Pharmaceutical recently instituted a lawsuit against Natco Pharma in the U.S.A alleging that the Indian drug manufacturer had made attempts to release a generic version of Taiho’s cancer drug – “Lonsurf.” The suit has been instituted in the United States District Court for the District Court of Delaware. As Taiho is anticipating the infringement of its drug, the company has sought for an injunction order against manufacturing, importing and selling the drug at issue.
Eli Lilly wins lawsuit instituted against Apotex Inc.
According to a recent announcement made by Eli Lilly, the U.S. District Court for the Southern District of Indiana has ruled in favor of the company with regard to a suit filed against Apotex for a potential act of infringement. Eli Lilly had instituted a suit alleging that the sale of alternative salt forms of a method of Chemotherapy called Pemetrexed, commonly known by its brand name Alimta, would infringe Lilly’s Alimta vitamin regimen patent. Eli Lily’s patent protecting the invention is said to expire in the month of May 2022. The U.S District Court said that if Apotex was to introduce and market alternative forms of the regimen before the expiry of the said patent, the act would result in infringement of Eli Lilly’s patent.
International Patent News
USPTO appoints new Chief Financial Officer
The United States Patent and Trademark Office (USPTO) recently announced the appointment its new Chief Financial Officer (CFO), Jay Hoffman. The new CFO will begin to discharge his duties from 6th January 2020 onwards. According to the official USPTO notification, the CFO will serve as the principal financial advisor to the USPTO’s Director and will also oversee an annual budget exceeding $3 billion.
Authored by Vibha Amarnath
About BIP’s Patent Attorneys
The patent news bulletin is brought to you by the patent division of BananaIP Counsels, a top patent and IP firm in India. Led by Senior Partners, Somashekar Ramakrishna, Nitin Nair and Vinita Radhakrishnan, BIP’s Patent Attorneys are among the leading patent practitioners in the country. They work with clients such as Mahindra and Mahindra, Samsung, HCL, Eureka Forbes, to name a few. The patent attorneys at BIP have strong technical and legal expertise in areas such as IT/Software, Artificial Intelligence (AI), Machine Learning, Data Analytics, Electronics and Telecommunication, Mechanical, Automotive, Green Energy, Traditional Medicine and Bio/Pharma domains. The firm is a first choice for clients looking for support in patent filing, prosecution, management and strategy in India, and across the world.
This weekly patent news bulletin is a part of their pro bono work, and is aimed at spreading patent awareness. You are free to share the news with appropriate attribution and backlink to the source.
If you have any questions, or need any clarifications, please feel free to write to [email protected]
Disclaimer: Kindly note that the news bulletin has been put together from different sources, primary and secondary, and BananaIP’s reporters may not have verified all the news published in the bulletin. You may write to [email protected] for corrections and take down.